Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Press release: Online availability of Sanofis half-year financial report for 2025
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31,…